Peter Farrell - Director, Arcturus Therapeutics Holdings Inc

As of June 22, 2021


Peter Farrell Net Worth

  • Net worth is estimated to be at least $251.66M
  • Owns at least 95,565 units of Arcturus Therapeutics Holdings Inc stock

Peter Farrell Trading

  • Largest purchase of shares was 9,113 units , worth over $99.67K on August 21, 2019
  • In total has made about 4 transactions over 2 years
  • Usually trades in June, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Peter Farrell Mailing Address

  • Mailing address is Resmed Inc 14040 Danielson Street Poway CA 92064-6857 CA

Arcturus Therapeutics Holdings Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph E. Payne 2020 $500,000 $450,000 $11,911,500 - $12,861,500
Joseph E. Payne 2019 $450,000 $243,000 $472,818 - $1,165,818
Joseph E. Payne 2018 $425,000 $372,532 $636,888 $1,252,624 $2,687,044
Dr. Padmanabh Chivukula 2020 $400,000 $240,000 $6,832,600 - $7,472,600
Dr. Padmanabh Chivukula 2019 $370,000 $133,200 $132,956 - $636,156
Dr. Padmanabh Chivukula 2018 $350,000 $83,233 $424,592 $515,080 $1,372,905
Andy Sassine, 2020 $400,000 $240,000 $7,014,800 - $7,654,800
Andy Sassine, 2019 $375,000 $150,000 $801,880 - $1,326,880
Andy Sassine, 2018 $120,000 - $126,340 - $246,340
Dr. Steven Hughes 2020 $415,000 $249,000 $4,212,625 - $4,876,625
Dr. Steven Hughes 2019 $299,873 - - - $299,873
Lance Kurata 2020 $156,250 $67,500 $4,916,800 - $5,140,550
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1768224/000119380521000583/e620530_def14a-arct.htm

Arcturus Therapeutics Holdings Inc Insider Trading

  • The most recent transaction was 10,000 units sold on November 3, 2021 by Pad Chivukula worth over $444.1K
  • In the last 2 years, insiders at Arcturus Therapeutics Holdings Inc sold an estimated value of $130.71M and bought an estimated value of $10.24M
  • The most active traders are Pad Chivukula, Chief Scientific Officer & COO,  Andy Sassine, Chief Financial Officer,  and Joseph Payne, President and CEO
  • Insider trading is most common in June, with the busiest year in 2020

Arcturus Therapeutics Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1